Skip to main content

Table 3 Average relative volumes of PTVs covered by 95% of prescription dose ( PV 95 ), and MPV 95 and STDPV 95 , and average ipsilateral lung volumes receiving more than 20 Gy ( LV 20 ) and Mean lung dose ( PM LD ) (Gy) from CVCT, MIP3, AVG and EE plans (treatment uncertainties included)

From: Evaluation and comparison of New 4DCT based strategies for proton treatment planning for lung tumors

  Case A B C D E F G H I J K L MPV 95 STDPV 95
PV 95 (%) CVCT plan 96.1 98.5 100 99.9 99.5 95.4 95.6 99.8 99.9 99.7 98.9 97.8 98.4 1.7
MIP3 plan 98.4 99.1 100 100 99.9 100 99.7 99.8 99.8 99.8 99.3 97.8 99.5 0.7
AVG plan 89.8 94.4 100 100 100 100 98.5 99.8 99.8 99.8 99.5 97.0 98.2 3.1
EE plan 96.8 99.7 100 99.9 100 100 99.6 99.9 100 99.8 99.8 97.4 99.4 1.1
LV 20 (%) CVCT plan 3.9 8.0 13.6 7.6 13.7 18.7 23.8 12.1 20.0 25.7 32.3 30.3   
MIP3 plan 5.1 8.4 15.1 9.3 13.7 18.6 23.0 11.5 18.2 25.9 32.8 30.8   
AVG plan 2.6 7.1 13.4 7.9 13.2 19.0 20.5 11.9 19.9 25.7 33.4 31.0   
EE plan 4.0 8.2 13.4 7.9 13.2 19.1 21.3 11.2 21.0 25.8 33.1 31.0   
PM LD (Gy) CVCT plan 2.4 3.9 6.7 4.3 6.3 8.4 10.8 6.7 9.1 13.0 15.7 14.7   
MIP3 plan 2.8 4.0 7.1 5.1 6.2 8.8 10.1 6.5 8.4 12.7 16.0 15.0   
AVG plan 1.7 3.4 6.6 4.4 6.1 8.6 9.6 6.5 8.8 12.7 16.3 15.1   
  EE plan 2.4 3.9 6.5 4.4 6.1 8.7 9.9 6.2 9.2 12.8 16.5 15.2